Mike Doolittle's Contact Details

Mike Doolittle's Company Details

NDRI

Philadelphia, PA, US • 50 - 99 Employees
Market Research

For 40 years, National Disease Research Interchange has revolutionized the progress of scientific research by partnering with organ and tissue donation programs to procure and distribute human biospecimens to biomedical researchers. The National Institutes of Health has provided funding to NDRI since 1987. Partnering for Progress Researchers in academic medical centers, non-profit research organizations, as well as pharmaceutical, biotechnology, and medical device companies rely on NDRI for access to quality human biospecimens and data in critical, high-demand areas of research. They have reported findings from research with NDRI biospecimens annually in more than 150 articles published in peer-reviewed scientific and medical publications. Human Biospecimens from NDRI are:• Customized: Acquisition and processing tailored to specific requirements • Timely: 24/7 response to requests and distribution of tissue• Diverse: Retrieval of normal and diseased organs and tissues from every part of the body • Ethical: Compliance with privacy, informed consent, and biomaterials handling regulations; distribution only to approved researchers• State-of-the-Art: Multiple tissue types, formats, and preservation methods available• NDRI also provides de-identified donor medical-social histories for select human biospecimens.